全文获取类型
收费全文 | 41238篇 |
免费 | 4053篇 |
国内免费 | 1182篇 |
专业分类
耳鼻咽喉 | 264篇 |
儿科学 | 476篇 |
妇产科学 | 475篇 |
基础医学 | 2615篇 |
口腔科学 | 1232篇 |
临床医学 | 5377篇 |
内科学 | 3854篇 |
皮肤病学 | 418篇 |
神经病学 | 1843篇 |
特种医学 | 1011篇 |
外国民族医学 | 8篇 |
外科学 | 3283篇 |
综合类 | 6243篇 |
现状与发展 | 1篇 |
一般理论 | 3篇 |
预防医学 | 7870篇 |
眼科学 | 290篇 |
药学 | 5123篇 |
91篇 | |
中国医学 | 4816篇 |
肿瘤学 | 1180篇 |
出版年
2024年 | 93篇 |
2023年 | 923篇 |
2022年 | 1279篇 |
2021年 | 1862篇 |
2020年 | 2047篇 |
2019年 | 1899篇 |
2018年 | 1759篇 |
2017年 | 1798篇 |
2016年 | 1727篇 |
2015年 | 1683篇 |
2014年 | 3131篇 |
2013年 | 3303篇 |
2012年 | 2806篇 |
2011年 | 2889篇 |
2010年 | 2232篇 |
2009年 | 2016篇 |
2008年 | 1868篇 |
2007年 | 1845篇 |
2006年 | 1570篇 |
2005年 | 1345篇 |
2004年 | 1120篇 |
2003年 | 1048篇 |
2002年 | 759篇 |
2001年 | 689篇 |
2000年 | 599篇 |
1999年 | 562篇 |
1998年 | 377篇 |
1997年 | 364篇 |
1996年 | 328篇 |
1995年 | 292篇 |
1994年 | 252篇 |
1993年 | 198篇 |
1992年 | 212篇 |
1991年 | 159篇 |
1990年 | 138篇 |
1989年 | 131篇 |
1988年 | 130篇 |
1987年 | 106篇 |
1986年 | 128篇 |
1985年 | 147篇 |
1984年 | 118篇 |
1983年 | 75篇 |
1982年 | 84篇 |
1981年 | 78篇 |
1980年 | 78篇 |
1979年 | 50篇 |
1978年 | 47篇 |
1977年 | 26篇 |
1974年 | 20篇 |
1973年 | 20篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
A molecular perspective for the use of type IV tyrosine kinase inhibitors as anticancer therapeutics
《Drug discovery today》2022,27(3):808-821
Tyrosine kinases are enzymes that can transfer a phosphate group from ATP to a specific protein tyrosine, serine or threonine residue within a cell, operating as a switch that can turn ‘on’ and ‘off’ causing different physiological alterations in the body. Mutated kinases have been shown to display an equilibrium shift toward the activated state. Types I–III have been studied intensively leading to drugs like imatinib (type II), cobimetinib (type III), among others. It is the same scenario for types V–VII; however, there is a lacuna in information regarding type IV inhibitors, although recently some advances have surfaced. This review aims to accumulate the knowledge gained so far about type IV inhibitors. 相似文献
2.
3.
4.
5.
[摘要]?目的?结合环介导等温扩增技术(loop-mediated isothermal amplification, LAMP)和微流控芯片技术,建立一种适合现场快速检测登革病毒的方法。方法?利用RT-LAMP,针对登革病毒基因组中3’非编码区中特异性序列进行扩增,建立基于微流控芯片技术的LAMP检测方法,优化检测体系,并对该方法的灵敏性和特异性进行评估。结果?基于LAMP 和微流控芯片技术的登革病毒检测方法,通过对病毒模板进行扩增,发现与其他病毒无交叉反应,特异性良好;同时,结果显示该方法对登革病毒检测灵敏性可达61.2 pg/μl,与实时荧光定量PCR仪所达到的检测灵敏性一致。结论?基于LAMP和微流控芯片技术的登革病毒检测方法具有操作简单、快速、对设备要求低等优势,并且灵敏性、特异性均较好,是一种便于开展现场快速检测的方法。 相似文献
6.
目的 建立一种能够快速鉴定人参和西洋参的双重实时荧光PCR方法。方法 通过对人参属及其近似种基因序列的分析比对,设计特异性的引物探针,建立双重实时荧光PCR检测方法。PCR反应体系为Premix Ex Taq (Probe qPCR) 10 μL,人参上下游引物各0.5 μL,西洋参上下游引物各0.3 μL,人参与西洋参特异性探针各0.4 μL,DNA模板2 μL,灭菌去离子水补至20 μL。反应条件为95℃预变性30 s;然后以95℃变性5 s,60℃退火延伸30 s进行40个循环。应用该方法测试了27份DNA样品,包括7份人参、6份西洋参、4份人参与西洋参混合样、10份其他人参属样品及其他常见中药材样品的DNA,以确定该方法的特异性。将人参与西洋参样品DNA混合后10倍稀释成不同浓度后进行检测,用以确定该方法的灵敏度。结果 人参及西洋参样品均在特定的荧光通道下出现典型的阳性扩增曲线,人参与西洋参混合样品均同时出现两条阳性扩增曲线,其它对照样品及空白对照均没有出现阳性扩增曲线。灵敏度检测结果显示该方法检测人参及西洋参的最低检测限均为2 pg DNA/反应。结论 本实验建立的双重实时荧光PCR方法能够同时快速、准确、灵敏地鉴别出人参和西洋参。 相似文献
7.
8.
《Pancreatology》2022,22(2):270-276
Backgroundand purpose: Zinc is an essential element for human health and plays an important role in metabolic, immunological and other biological processes. The present study was conducted to investigate the association between zinc deficiency (ZD) and the perioperative clinical course in patients with pancreatic ductal adenocarcinoma (PDAC).MethodsOf 216 patients with PDAC who underwent elective pancreatectomy between 2013 and 2017 at our institution, 206 patients with sufficient clinical data were retrospectively reviewed. The perioperative variables were compared and the risk factors associated with infectious complications were identified.ResultsZD was preoperatively present in 36 (17.5%) of 206 patients with PDAC. In the patients of the ZD group, a higher proportion of males, higher preoperative modified Glasgow prognostic scores, a higher neutrophil-to-lymphocyte ratio, and a higher occurrence of postoperative infectious complications after pancreatectomy were observed, compared to the non-ZD group. By a univariate analysis, three risk factors were significantly associated with infectious complications after pancreatectomy: ZD (vs non-ZD: p = 0.002), serum albumin <3.5 g/dl (vs ≥ 3.5 g/dl: p = 0.005), and the procedure of pancreaticoduodenectomy (vs others: p = 0.013). By multivariate logistic regression analysis, the occurrence of infectious complications was significantly associated with ZD (OR 3.430, 95%CI 1.570 to 7.490, p = 0.002) and the procedure of pancreaticoduodenectomy (OR 2.030, 95%CI 1.090 to 3.770, p = 0.025).ConclusionsThe current study newly demonstrated that ZD could serve as a preoperative predictor of infectious complications after pancreatectomies in the patients with PDAC. 相似文献
10.
《Value in health》2022,25(6):1018-1029
ObjectivesThis study aimed to explore quality-adjusted life-year (QALY) and subsequent cost-effectiveness estimates based on the more physical health–focused EQ-5D 5-level version (EQ-5D-5L) value set for England or cross-walked EQ-5D 3-level version UK value set scores or more mental health recovery-focused Recovering Quality of Life Utility Index (ReQoL-UI), when using alternative within-trial statistical methods. We describe possible reasons for the different QALY estimates based on the interaction between item scores, health state profiles, preference-based scores, and mathematical and statistical methods chosen.MethodsQALYs are calculated over 8 weeks from a case study 2:1 (intervention:control) randomized controlled trial in patients with anxiety or depression. Complete case and with missing cases imputed using multiple-imputation analyses are conducted, using unadjusted and regression baseline-adjusted QALYs. Cost-effectiveness is judged using incremental cost-effectiveness ratios and acceptability curves. We use previously established psychometric results to reflect on estimated QALYs.ResultsA total of 361 people (241:120) were randomized. EQ-5D-5L crosswalk produced higher incremental QALYs than the value set for England or ReQoL-UI, which produced similar unadjusted QALYs, but contrasting baseline-adjusted QALYs. Probability of cost-effectiveness <£30 000 per QALY ranged from 6% (complete case ReQoL-UI baseline-adjusted QALYs) to 64.3% (multiple-imputation EQ-5D-5L crosswalk unadjusted QALYs). The control arm improved more on average than the intervention arm on the ReQoL-UI, a result not mirrored on the EQ-5D-5L nor condition-specific (Patient-Health Questionnaire-9, depression; Generalized Anxiety Disorder-7, anxiety) measures.ConclusionsReQoL-UI produced contradictory cost-effectiveness results relative to the EQ-5D-5L. The EQ-5D-5L’s better responsiveness and “anxiety/depression” and “usual activities” items drove the incremental QALY results. The ReQoL-UI’s single physical health item and “personal recovery” construct may have influenced its lower 8-week incremental QALY estimates in this patient sample. 相似文献